Hamid Khoja

Hamid Khoja, Chief Scientific Officer, FibroBiologics

Content by Hamid Khoja:

 Research Field Cell & gene therapy

(Fibro)Blast-off!

| Hamid Khoja | 4 min read

In regenerative medicines and therapeutics, fibroblasts can offer significant advantages over stem cells, says Hamid Khoja
Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register

October Issue of The Translational Scientist